Furthermore, ROC to evaluate the diagnostic utility of HULC indicates that serum HULC provides a more powerful differential ability than CEA and CA72-4, suggesting that serum HULC could serve as a promising tumor marker for GC diagnosis. The gene discussed is CEACAM5; the disease is gastric cancer.